
O1-8-4 [Encore]Dose justification for [fam-] trastuzumab deruxtecan (DS-8201a) in HER2-positive breast cancer
Takahashi, Shunji, Modi, Shanu, Tsurutani, Junji, Krop, Ian E, Iwata, Hiroji, Wada, Russell, Yin, Ophelia, Garimella, Tushar, Sugihara, Masahiro, Zhang, Lin, Lee, Caleb, Saito, Kaku, Kawasaki, Yui, YvVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz339.009
Date:
October, 2019
Fichier:
PDF, 79 KB
2019